Clinical trial
The Treatment of T1N0 Invasive Breast Carcinoma by Local Excision and Interstitial Implant
NCT00977275 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Treatment of T1N0 Invasive Breast Carcinoma by Local Excision and Interstitial Implant
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- June 30, 1997
- Completion date
- May 31, 2013
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer